{'fraction_non_alphanumeric': 0.03151618398637138, 'fraction_numerical': 0.03236797274275979, 'mean_word_length': 4.7317073170731705, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Methodological and clinical evaluation of a microplate assay of endotoxin in whole blood sample].

We have developed a simple, rapid method for determining endotoxin in whole blood using a microtiter plate. The samples were pretreated with 0.66 mol/l nitric acid containing 0.25% Triton X-100; the supernatants were placed in a microtiter plate well, and incubated with endotoxin-specific chromogenic limulus test reagent (Endospecy; Seikagaku Corporation). The calibration curve was linear from 0 to 50 pg/ml of Escherichia coli 0111: B4 endotoxin with a variation coefficient less than 5%. The recovery of endotoxin added to human and experimental animals was about 100% without being affected by dilution. The normal endotoxin level in human whole blood was less than 10 pg/ml in reference to E. coli 0111: B4 endotoxin. The results in 120 patients with various diseases correlated well with those determined by a conventional method using plasma as a sample (r = 0.877; p less than 0.05). Whole blood sample has advantages over plasma in that it allows all endotoxin in a sample to be determined, requires a smaller amount of sample, and has less risk of contamination.